Muscle contractions stimulate glucose uptake through insulin-independent pathways, immediately lowering blood sugar
Considered the newest GLP-1based therapy on the horizon, retatrutide is a triple receptor agonist that targets GLP-1, GIP, and glucagon receptors
Jensen MT, Nielsen SS, Jessen-Winge C, Madsen CMT, Thilsing T, Larrabee Snderlund A, et al
For best results, try to weigh yourself once to thrice per week, after using the restroom in the morning but before eating or drinking anything
In one phase 2 study: Pancreatitis was reported in about 0.4% of participants (1 out of 267) Gallbladder issues affected roughly 1.1%, with no cases in the placebo group Heart rhythm changes were reported more often in people taking retatrutide (about 6% compared to 3% with placebo) Liver enzyme increases were rare (around 1%), and overall liver health markers stayed stable over time
Its always best to err on the side of caution and consult your healthcare provider or pharmacist before injecting